미국의 의료 IT 소프트웨어 시장 규모, 점유율 및 동향 분석 보고서 : 소프트웨어 유형별, 부문별 예측(2026-2033년)

U.S. Healthcare IT Software Market Summary

The U.S. healthcare IT software market size was valued at USD 189.6 billion in 2025 and is projected to grow from USD 216.5 billion in 2026 to USD 634.0 billion by 2033, at a CAGR of 16.6% from 2026 to 2033. The increasing adoption of electronic health records (EHRs) and electronic medical records (EMRs), fueled by federal mandates and initiatives such as the HITECH Act, has significantly expanded the market. Rising demand for interoperability, a shift towards value-based care, and population health management have further accelerated the adoption of healthcare analytics software.

U.S. Healthcare IT Software Market Segmentation

This report forecasts revenue growth at the country levels and provides an analysis of industry trends across each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the U.S. healthcare IT software market on the basis of software type.

• Software Type Outlook (Revenue, USD Million, 2021 - 2033)
• Revenue Cycle Management Software
  • Integrated
  • Standalone
• Tele-healthcare Software
  • Tele-care
  • Activity Monitoring
  • Remote Medication Management
  • Tele-Health
  • LTC Monitoring
  • Video Consultation
• Population Health Management (PHM) Software
• Cloud-based EHR & EMR Software
• Clinical Information Software
• Technology Solutions in the Healthcare Payers Software
  • Claims Management
  • Enrollment and Member Management
  • Provider Management
  • Revenue Management and Billing
  • Analytics
  • Value based Payments
  • Data management and support
  • Personalize/CRM
  • Clinical Decision Support
  • Others
• Healthcare Customer Relationship Management (CRM) Software
  • Sales
  • Customer Service and Support
  • Marketing
  • Digital Commerce
  • Cross -CRM
• eClinical Software
  • Clinical Trial Management System (CTMS)
  • Electronic Clinical Outcome Assessment (eCOA)
  • Electronic Data Capture (EDC) & CDMS
  • Clinical Data Integration Platforms
  • Clinical Analytics Platforms
  • Safety Solutions
  • Electronic Trial Master File (eTMF)
  • Randomization and Trial Supply Management (RTSM)
  • eConsent
• Healthcare Analytics Software
  • Descriptive Analytics
  • Diagnostic Analytics
  • Predictive Analytics
  • Prescriptive Analytics
• Medical Imaging Information Software
  • Radiology Information Software
  • Monitoring Analysis Software
  • Picture Archiving and Communication Software
• Electronic Prescribing Software (E-Prescribing Solutions)
• Computerized Provider Order Entry Software
• Laboratory Information Software
• Digital Healthcare Supply Chain Management Software

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Software Type
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Widespread Adoption of Electronic Health Records (EHR) and Electronic Medical Records (EMR)
    • 3.2.1.2. Growing demand for remote patient monitoring for improved out-of- hospital care
    • 3.2.1.3. Technologically advanced healthcare IT infrastructure
    • 3.2.1.4. Increase in the number of initiatives and investments supporting eHealth and digital health
    • 3.2.1.5. Rise in healthcare expenditure prompting cost-cutting initiatives
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of data privacy
    • 3.2.2.2. Lack of medical expertise
  • 3.2.3. Industry Opportunity Analysis
  • 3.2.4. Industry Challenge Analysis
• 3.3. Regulatory Overview
  • 3.3.1. HIPAA Compliance Landscape
  • 3.3.2. ONC Interoperability & Information Blocking Rules (21st Century Cures Act)
  • 3.3.3. CMS Reimbursement Policy Impact
  • 3.3.4. FDA Regulations (for SaMD / AI-based clinical tools)
• 3.4. Technology Overview
  • 3.4.1. Computerized Provider Order Entry Systems
  • 3.4.2. Electronic Prescribing Systems (E-Prescribing Solutions)
  • 3.4.3. Laboratory Information
  • 3.4.4. Clinical Information Systems
  • 3.4.5. Medical Imaging Information Systems
  • 3.4.6. Tele-healthcare
  • 3.4.7. Revenue Cycle Management
  • 3.4.8. eClinical Solutions
  • 3.4.9. Population Health Management (PHM)
  • 3.4.10. Digital Healthcare Supply Chain Management
  • 3.4.11. Healthcare Customer Relationship Management (CRM)
  • 3.4.12. Technology Solutions in Healthcare Payers
  • 3.4.13. Healthcare Analytics
• 3.5. U.S. Healthcare IT Software Industry- Case Study Insights
• 3.6. Business Environment Analysis
  • 3.6.1. Porter's Five Forces Analysis
    • 3.6.1.1. Supplier power
    • 3.6.1.2. Buyer power
    • 3.6.1.3. Substitution threat
    • 3.6.1.4. Threat of new entrant
    • 3.6.1.5. Competitive rivalry
  • 3.6.2. PESTLE Analysis
    • 3.6.2.1. Political landscape
    • 3.6.2.2. Economic and Social landscape
    • 3.6.2.3. Technological landscape
    • 3.6.2.4. Environmental landscape
    • 3.6.2.5. Legal Landscape

Chapter 4. U.S. Healthcare IT Software Market: Software Type Estimates & Trend Analysis

• 4.1. Software Type Segment Dashboard
• 4.2. Software Type Market Share Movement Analysis, 2025 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Software Type, 2021 to 2033 (USD Million)
• 4.4. Computerized Provider Order Entry Systems
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Electronic Prescribing Systems (E-Prescribing Solutions)
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Laboratory Information
  • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Clinical Information Systems
  • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Medical Imaging Information Systems
  • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.2. Radiology Information Systems
    • 4.8.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.3. Monitoring Analysis Software
    • 4.8.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.4. Picture Archiving and Communication Systems
    • 4.8.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Tele-healthcare
  • 4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9.2. Tele-care
    • 4.9.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9.3. Tele-Health
    • 4.9.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Revenue Cycle Management
  • 4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10.2. Integrated
    • 4.10.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10.3. Standalone
    • 4.10.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.11. eClinical Solutions
  • 4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11.2. Electronic Clinical Outcome Assessment (eCOA)
    • 4.11.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11.3. Electronic Data Capture (EDC) & CDMS
    • 4.11.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11.4. Clinical Analytics Platforms
    • 4.11.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11.5. Clinical Data Integration Platforms
    • 4.11.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11.6. Safety Solutions
    • 4.11.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11.7. Clinical Trial Management System (CTMS)
    • 4.11.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11.8. Randomization and Trial Supply Management (RTSM)
    • 4.11.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11.9. Electronic Trial Master File (eTMF)
    • 4.11.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11.10. eConsent
    • 4.11.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.12. Population Health Management (PHM)
  • 4.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.13. Digital Healthcare Supply Chain Management
  • 4.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.14. Healthcare Customer Relationship Management (CRM)
  • 4.14.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.14.2. Customer Service and Support
    • 4.14.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.14.3. Digital Commerce
    • 4.14.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.14.4. Marketing
    • 4.14.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.14.5. Sales
    • 4.14.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.14.6. Cross -CRM
    • 4.14.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.15. Technology Solutions in the Healthcare Payers
  • 4.15.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.15.2. Enrollment and Member Management
    • 4.15.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.15.3. Provider Management
    • 4.15.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.15.4. Claims Management
    • 4.15.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.15.5. Value based Payments
    • 4.15.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.15.6. Revenue Management and Billing
    • 4.15.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.15.7. Analytics
    • 4.15.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.15.8. Personalize/CRM
    • 4.15.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.15.9. Clinical Decision Support
    • 4.15.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.15.10. Data management and support
    • 4.15.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.15.11. Others
    • 4.15.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.16. Healthcare Analytics
  • 4.16.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.16.2. Descriptive Analysis
    • 4.16.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.16.3. Predictive Analysis
    • 4.16.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.16.4. Prescriptive Analysis
    • 4.16.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Competitive Landscape

• 5.1. Participant Overview
• 5.2. Company Market Position Analysis
• 5.3. Company Categorization
• 5.4. Company Profiles/Listing
  • 5.4.1. Koninklijke Philips N.V.
    • 5.4.1.1. Overview
    • 5.4.1.2. Financial performance
    • 5.4.1.3. Product benchmarking
    • 5.4.1.4. Strategic initiatives
  • 5.4.2. McKesson Corporation
    • 5.4.2.1. Overview
    • 5.4.2.2. Financial performance
    • 5.4.2.3. Product benchmarking
    • 5.4.2.4. Strategic initiatives
  • 5.4.3. eMDs, Inc.
    • 5.4.3.1. Overview
    • 5.4.3.2. Financial performance
    • 5.4.3.3. Product benchmarking
    • 5.4.3.4. Strategic initiatives
  • 5.4.4. Veradigm Inc. (formerly Allscripts Healthcare Solutions, Inc.)
    • 5.4.4.1. Overview
    • 5.4.4.2. Financial performance
    • 5.4.4.3. Product benchmarking
    • 5.4.4.4. Strategic initiatives
  • 5.4.5. Athenahealth, Inc. (Acquired by Hellman & Friedman and Bain Capital)
    • 5.4.5.1. Overview
    • 5.4.5.2. Financial performance
    • 5.4.5.3. Product benchmarking
    • 5.4.5.4. Strategic initiatives
  • 5.4.6. Carestream Health
    • 5.4.6.1. Overview
    • 5.4.6.2. Financial performance
    • 5.4.6.3. Product benchmarking
    • 5.4.6.4. Strategic initiatives
  • 5.4.7. GE Healthcare
    • 5.4.7.1. Overview
    • 5.4.7.2. Financial performance
    • 5.4.7.3. Product benchmarking
    • 5.4.7.4. Strategic initiatives
  • 5.4.8. Agfa- Gevaert Group
    • 5.4.8.1. Overview
    • 5.4.8.2. Financial performance
    • 5.4.8.3. Product benchmarking
    • 5.4.8.4. Strategic initiatives
  • 5.4.9. Hewlett Packard Enterprise Development LP
    • 5.4.9.1. Overview
    • 5.4.9.2. Financial performance
    • 5.4.9.3. Product benchmarking
    • 5.4.9.4. Strategic initiatives
  • 5.4.10. Novarad
    • 5.4.10.1. Overview
    • 5.4.10.2. Financial performance
    • 5.4.10.3. Product benchmarking
    • 5.4.10.4. Strategic initiatives
  • 5.4.11. Optum, Inc.
    • 5.4.11.1. Overview
    • 5.4.11.2. Financial performance
    • 5.4.11.3. Product benchmarking
    • 5.4.11.4. Strategic initiatives
  • 5.4.12. IBM
    • 5.4.12.1. Overview
    • 5.4.12.2. Financial performance
    • 5.4.12.3. Product benchmarking
    • 5.4.12.4. Strategic initiatives
  • 5.4.13. Oracle
    • 5.4.13.1. Overview
    • 5.4.13.2. Financial performance
    • 5.4.13.3. Product benchmarking
    • 5.4.13.4. Strategic initiatives
  • 5.4.14. SAS Institute, Inc.
    • 5.4.14.1. Overview
    • 5.4.14.2. Financial performance
    • 5.4.14.3. Product benchmarking
    • 5.4.14.4. Strategic initiatives
  • 5.4.15. IQVIA
    • 5.4.15.1. Overview
    • 5.4.15.2. Financial performance
    • 5.4.15.3. Product benchmarking
    • 5.4.15.4. Strategic initiatives
  • 5.4.16. Verisk Analytics, Inc.
    • 5.4.16.1. Overview
    • 5.4.16.2. Financial performance
    • 5.4.16.3. Product benchmarking
    • 5.4.16.4. Strategic initiatives
  • 5.4.17. SAP
    • 5.4.17.1. Overview
    • 5.4.17.2. Financial performance
    • 5.4.17.3. Product benchmarking
    • 5.4.17.4. Strategic initiatives
  • 5.4.18. Accenture
    • 5.4.18.1. Overview
    • 5.4.18.2. Financial performance
    • 5.4.18.3. Product benchmarking
    • 5.4.18.4. Strategic initiatives